684 related articles for article (PubMed ID: 7961551)
21. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
Barnes TR
Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
Dufresne RL; Wagner RL
J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
[TBL] [Abstract][Full Text] [Related]
23. [Current data on neurologic sequelae caused by neuroleptics].
Krebs MO
Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
[TBL] [Abstract][Full Text] [Related]
24. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
Friedman JH
Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
[TBL] [Abstract][Full Text] [Related]
25. Treating extrapyramidal reactions: some current issues.
Gelenberg AJ
J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
[TBL] [Abstract][Full Text] [Related]
26. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
27. Clozapine in tardive dyskinesia: observations from human and animal model studies.
Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
Tarsy D; Baldessarini RJ
Mov Disord; 2006 May; 21(5):589-98. PubMed ID: 16532448
[TBL] [Abstract][Full Text] [Related]
29. Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects.
Peacock L; Solgaard T; Lublin H; Gerlach J
Psychopharmacology (Berl); 1996 Mar; 124(1-2):188-96. PubMed ID: 8935815
[TBL] [Abstract][Full Text] [Related]
30. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome.
Shirzadi AA; Ghaemi SN
Harv Rev Psychiatry; 2006; 14(3):152-64. PubMed ID: 16787887
[TBL] [Abstract][Full Text] [Related]
31. Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia.
Casey DE
J Clin Psychiatry; 1998; 59 Suppl 3():31-7. PubMed ID: 9541336
[TBL] [Abstract][Full Text] [Related]
32. Treatment of clozapine-associated tardive dyskinesia.
Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
[No Abstract] [Full Text] [Related]
33. [Pisa syndrome in clozapine therapy].
Kurtz G; Kapfhammer HP; Peuker B
Nervenarzt; 1993 Nov; 64(11):742-6. PubMed ID: 8278016
[TBL] [Abstract][Full Text] [Related]
34. Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesia.
Wirshing WC; Phelan CK; van Putten T; Marder SR; Engel J
J Clin Psychopharmacol; 1990 Oct; 10(5):371-3. PubMed ID: 1979566
[No Abstract] [Full Text] [Related]
35. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
36. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
Gerlach J
J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
[TBL] [Abstract][Full Text] [Related]
37. [Iatrogenic extrapyramidal disorders].
Ludin HP
Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects.
Kim JH; Byun HJ
Clin Neuropharmacol; 2003; 26(6):312-6. PubMed ID: 14646611
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of 15 patients with tardive dystonia.
Sachdev P
Am J Psychiatry; 1993 Mar; 150(3):498-500. PubMed ID: 8094600
[TBL] [Abstract][Full Text] [Related]
40. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
Barnes TR; McPhillips MA
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
